Biotech & AI drug discoverySTAT — Biotech

STAT+: Revolution Medicines' pancreatic cancer drug has stunning commercial debut

According to STAT, Rasonque, Revolution Medicines' new pancreatic cancer drug, is off to one of the best oncology drug launches in history, based on its early commercial performance. No long-term data is mentioned in the report.

AI summary · generated only from source feed metadata; consult original

Source published2026-11-05T12:33:01+00:00

Published here2026-11-05T13:44:40+00:00

Original source

STAT — Biotech

Media report · consult original reporting

Read the original ↗https://www.statnews.com/2026/11/05/rasonque-revolution-medicines-pancreatic-cancer-commercial-launch/

Original headline

STAT+: Revolution Medicines’ pancreatic cancer drug has stunning commercial debut

AI bilingual edit · consult original

Headlines are indexed or machine translated, not independent verification of scientific results. Medical news is not clinical advice. Distinguish interstellar concepts from demonstrated space technology using the original source.